Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-24

FDA Approved: CHLORTHALIDONE — Original Application (TAGI Pharma, Inc.)

View source ↗

Summary

FDA approved the original application for chlorthalidone from TAGI Pharma, confirming marketing authorization for this generic diuretic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorthalidone (chlorthalidone)

Snippet

ORIG AP for CHLORTHALIDONE (CHLORTHALIDONE)